Clindamycin 15 MG/ML Oral Solution

Known as: CLINDAMYCIN PALMITATE HYDROCHLORIDE 75 mg in 5 mL ORAL GRANULE, FOR SOLUTION [CLINDAMYCIN PALMITATE HYDROCHLORIDE (Pediatric)], CLINDAMYCIN PALMITATE HYDROCHLORIDE 75 mg in 5 mL ORAL SOLUTION, clindamycin palmitate HCl 75 MG in 5 mL Oral Solution 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1992-2016
01219922016

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Dietary saturated fatty acids (SFA) in excess not only induce hepatic insulin resistance, but also result in type 2 diabetes… (More)
Is this relevant?
2016
2016
BACKGROUND & AIMS Nonalcoholic fatty liver disease (NAFLD) represents the most common chronic liver disease in industrialized… (More)
Is this relevant?
2014
2014
The objective of this study was to encapsulate iron in nanocarriers formulated with ascorbyl palmitate and 1,2-distearoyl-sn… (More)
Is this relevant?
2013
2013
The accumulation of long-chain fatty acids (LCFAs) in non-adipose tissues results in lipid-induced cytotoxicity (or lipoapoptosis… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2009
2009
BACKGROUND The biochemical diagnosis of mitochondrial fatty acid oxidation defects (FAOD) currently rests on enzyme assays. A… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • table 1
Is this relevant?
1992
1992
A 74 year-old woman, who had been diagnosed as AML (M3) in poor condition, was treated with Retinol Palmitate (Chocola-A, 150,000… (More)
Is this relevant?